DK1924585T3 - Hidtil ukendt krystallinsk for af et pyridazino[4,5-b]indol-derivat - Google Patents
Hidtil ukendt krystallinsk for af et pyridazino[4,5-b]indol-derivatInfo
- Publication number
- DK1924585T3 DK1924585T3 DK06813757.9T DK06813757T DK1924585T3 DK 1924585 T3 DK1924585 T3 DK 1924585T3 DK 06813757 T DK06813757 T DK 06813757T DK 1924585 T3 DK1924585 T3 DK 1924585T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyridazino
- hitherto
- lining
- crystalline
- indole derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71215305P | 2005-08-29 | 2005-08-29 | |
PCT/US2006/033254 WO2007027525A1 (en) | 2005-08-29 | 2006-08-24 | Novel crystalline form of a pyridazino [4 , 5-b] indole derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1924585T3 true DK1924585T3 (da) | 2012-02-27 |
Family
ID=37546937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06813757.9T DK1924585T3 (da) | 2005-08-29 | 2006-08-24 | Hidtil ukendt krystallinsk for af et pyridazino[4,5-b]indol-derivat |
Country Status (32)
Country | Link |
---|---|
US (1) | US7683062B2 (pl) |
EP (1) | EP1924585B1 (pl) |
JP (1) | JP5063600B2 (pl) |
KR (2) | KR20080050577A (pl) |
CN (1) | CN101253176B (pl) |
AR (1) | AR057099A1 (pl) |
AT (1) | ATE531717T1 (pl) |
AU (1) | AU2006285142B2 (pl) |
BR (1) | BRPI0615259A2 (pl) |
CA (1) | CA2619284C (pl) |
CR (1) | CR9723A (pl) |
CY (1) | CY1112317T1 (pl) |
DK (1) | DK1924585T3 (pl) |
EA (1) | EA014164B1 (pl) |
EC (1) | ECSP088209A (pl) |
ES (1) | ES2375841T3 (pl) |
HK (1) | HK1123794A1 (pl) |
HR (1) | HRP20120073T1 (pl) |
IL (1) | IL189276A (pl) |
MA (1) | MA30000B1 (pl) |
NO (1) | NO20081365L (pl) |
NZ (1) | NZ566087A (pl) |
PL (1) | PL1924585T3 (pl) |
PT (1) | PT1924585E (pl) |
RS (1) | RS52318B (pl) |
SI (1) | SI1924585T1 (pl) |
TN (1) | TNSN08059A1 (pl) |
TW (1) | TW200813060A (pl) |
UA (1) | UA91716C2 (pl) |
UY (1) | UY29771A1 (pl) |
WO (1) | WO2007027525A1 (pl) |
ZA (1) | ZA200801890B (pl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2755334T3 (es) * | 2003-11-17 | 2020-04-22 | Merck & Cie | Proceso para la preparación de formas cristalinas B de clorhidrato de (6R)-L-eritro-tetrahidrobiopterina a partir de otras formas cristalinas |
EP1776365B1 (en) * | 2004-06-02 | 2011-08-03 | Sandoz Ag | Meropenem intermediate in crystalline form |
KR101314158B1 (ko) * | 2005-09-21 | 2013-10-04 | 4에스체 악티엔게젤샤프트 | 히스톤 탈아세틸 효소 억제제로서의 설포닐피롤 염산염 |
WO2007053427A2 (en) * | 2005-10-31 | 2007-05-10 | Janssen Pharmaceutica N.V. | Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives |
EA016054B1 (ru) * | 2006-06-16 | 2012-01-30 | Х. Лундбекк А/С | Кристаллические формы 4-[2-(4-метилфенилсульфанил)фенил] пиперидина с объединенным ингибированием повторного поглощения серотонина и норадреналина для лечения невропатической боли |
AU2007318132B2 (en) * | 2006-10-27 | 2012-11-08 | Signal Pharmaceuticals, Llc | Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith |
EP2085397A1 (en) * | 2008-01-21 | 2009-08-05 | Esteve Quimica, S.A. | Crystalline form of abacavir |
US7935817B2 (en) * | 2008-03-31 | 2011-05-03 | Apotex Pharmachem Inc. | Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof |
AR071318A1 (es) * | 2008-04-15 | 2010-06-09 | Basilea Pharmaceutica Ag | Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso |
US8097719B2 (en) * | 2008-07-15 | 2012-01-17 | Genesen Labs | Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem |
RU2011110241A (ru) * | 2008-08-18 | 2012-09-27 | САНОФИ-АВЕНТИС Ю.Эс. ЭлЭлСи (US) | СПОСОБ ПОЛУЧЕНИЯ ПОЛИМОРФА 7-ХЛОР-N,N,5-ТРИМЕТИЛ-4-ОКСО-3-ФЕНИЛ-3,5-ДИГИДРО-4Н-ПИРИДАЗИНО[4,5-b]ИНДОЛ-1-АЦЕТАМИДА |
RU2545456C2 (ru) | 2010-03-12 | 2015-03-27 | Омерос Корпорейшн | Pde10 ингибиторы и содержащие их композиции и способы |
CA2808904A1 (en) * | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Non-hygroscopic salts of 5-ht2c agonists |
EP2760859A1 (en) * | 2011-09-30 | 2014-08-06 | Sunshine Lake Pharma Co., Ltd | Crystalline forms of azilsartan and preparation and uses thereof |
NZ630803A (en) * | 2014-04-28 | 2016-03-31 | Omeros Corp | Optically active pde10 inhibitor |
NZ630810A (en) | 2014-04-28 | 2016-03-31 | Omeros Corp | Processes and intermediates for the preparation of a pde10 inhibitor |
JP2018513153A (ja) | 2015-04-24 | 2018-05-24 | オメロス コーポレーション | Pde10インヒビターならびに関連する組成物および方法 |
US9920045B2 (en) | 2015-11-04 | 2018-03-20 | Omeros Corporation | Solid state forms of a PDE10 inhibitor |
CN111303230B (zh) * | 2020-03-09 | 2021-07-13 | 中国食品药品检定研究院 | 一种***共晶物及其制备方法和用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2766823B1 (fr) * | 1997-07-30 | 1999-10-08 | Synthelabo | Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique |
FR2788696B1 (fr) | 1999-01-26 | 2004-03-05 | Synthelabo | Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central |
FR2829939B3 (fr) | 2001-09-21 | 2003-11-28 | Sanofi Synthelabo | Utilisation du 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5- dihydro-4h-pyridazino(4,5-b)indole-1-acetamide pour la preparation de medicaments destines au traitement de la polyarthrite rhumatoide |
WO2005034999A2 (en) | 2003-10-10 | 2005-04-21 | Bvm Holding Co. | Composition comprising association complex of a pharmaceutical and a poloxamer |
-
2006
- 2006-08-24 RS RS20120032A patent/RS52318B/en unknown
- 2006-08-24 SI SI200631252T patent/SI1924585T1/sl unknown
- 2006-08-24 PT PT06813757T patent/PT1924585E/pt unknown
- 2006-08-24 ZA ZA200801890A patent/ZA200801890B/xx unknown
- 2006-08-24 PL PL06813757T patent/PL1924585T3/pl unknown
- 2006-08-24 AT AT06813757T patent/ATE531717T1/de active
- 2006-08-24 CA CA2619284A patent/CA2619284C/en not_active Expired - Fee Related
- 2006-08-24 DK DK06813757.9T patent/DK1924585T3/da active
- 2006-08-24 EP EP06813757A patent/EP1924585B1/en active Active
- 2006-08-24 UA UAA200803953A patent/UA91716C2/ru unknown
- 2006-08-24 NZ NZ566087A patent/NZ566087A/en not_active IP Right Cessation
- 2006-08-24 JP JP2008529130A patent/JP5063600B2/ja not_active Expired - Fee Related
- 2006-08-24 BR BRPI0615259-7A patent/BRPI0615259A2/pt not_active IP Right Cessation
- 2006-08-24 AU AU2006285142A patent/AU2006285142B2/en not_active Ceased
- 2006-08-24 ES ES06813757T patent/ES2375841T3/es active Active
- 2006-08-24 KR KR1020087004953A patent/KR20080050577A/ko active IP Right Grant
- 2006-08-24 KR KR1020137018636A patent/KR20130087059A/ko not_active Application Discontinuation
- 2006-08-24 CN CN2006800314750A patent/CN101253176B/zh not_active Expired - Fee Related
- 2006-08-24 EA EA200800716A patent/EA014164B1/ru not_active IP Right Cessation
- 2006-08-24 WO PCT/US2006/033254 patent/WO2007027525A1/en active Application Filing
- 2006-08-28 AR ARP060103740A patent/AR057099A1/es not_active Application Discontinuation
- 2006-08-29 TW TW095131681A patent/TW200813060A/zh unknown
- 2006-08-29 UY UY29771A patent/UY29771A1/es unknown
-
2008
- 2008-02-04 IL IL189276A patent/IL189276A/en not_active IP Right Cessation
- 2008-02-06 TN TNP2008000059A patent/TNSN08059A1/en unknown
- 2008-02-11 CR CR9723A patent/CR9723A/es unknown
- 2008-02-14 US US12/031,243 patent/US7683062B2/en not_active Expired - Fee Related
- 2008-02-20 EC EC2008008209A patent/ECSP088209A/es unknown
- 2008-03-14 NO NO20081365A patent/NO20081365L/no not_active Application Discontinuation
- 2008-03-17 MA MA30757A patent/MA30000B1/fr unknown
-
2009
- 2009-02-19 HK HK09101601.0A patent/HK1123794A1/xx not_active IP Right Cessation
-
2012
- 2012-01-23 HR HRP20120073TT patent/HRP20120073T1/hr unknown
- 2012-01-26 CY CY20121100092T patent/CY1112317T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1924585T3 (da) | Hidtil ukendt krystallinsk for af et pyridazino[4,5-b]indol-derivat | |
ZA200609225B (en) | Indole derivatives having piperidine rings | |
DK1924151T3 (da) | Oral frigivelsessystem med styret frigivelse | |
DK1883451T3 (da) | Substituerede indolforbindelser med NOS-hæmmende virkning | |
DK1863833T3 (da) | Fremgangsmåde til fremstilling af makrocykliske forbindelser | |
ATE501119T1 (de) | Entzündungshemmende indol-derivate | |
MA28347A1 (fr) | Dérivés de quinoléine substitués | |
DK1737461T3 (da) | Carbolin-derivater til inhibering af angiogenese | |
PL2067108T3 (pl) | Lokalizowanie węzłów odniesienia do pozycjonowania | |
DK1710241T3 (da) | Intermediatforbindelser til fremstilling af trans-5-chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol | |
GB0419481D0 (en) | Isoindolin-1-one derivatives | |
DK1756049T3 (da) | Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater | |
EP1915354A4 (en) | INNOVATIVE BENZOTHIAZOLONE DERIVATIVES | |
DK1874766T3 (da) | Krystallinsk form af en quinolinon-carboxamid-forbindelse | |
EP1893625A4 (en) | PROCESS FOR THE PREPARATION OF 9-DEAZAPURINE DERIVATIVES | |
BRPI0716554A2 (pt) | compostos de mÉtodos para agentes rotulados de 18f | |
DK2213654T3 (da) | Fremgangsmåde til fremstilling af 2-amino-5-brombenzamid derivater | |
DK1838683T3 (da) | Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater | |
DK1784183T3 (da) | Fremgangsmåder til fremstilling af isothiazolderivater | |
IL190729A0 (en) | Methods for preparing glutamic acid derivatives | |
GB0405334D0 (en) | Method for exchanging signals via nodes | |
EP1919871A4 (en) | PROCESS FOR SYNTHESIS OF CHINOLINE DERIVATIVES | |
DK1682541T3 (da) | Fremgangsmåde til fremstilling af tiotropiumsalte | |
DK1888613T3 (da) | Fremgangsmåde til fremstilling af thiophenglycosidderivater | |
EP1880995A4 (en) | METHOD OF SYNTHESIZING AN INDOLE DERIVATIVE COMPRISING A PIPERIDINE CYCLE |